跳至主要内容
临床试验/NCT06116955
NCT06116955已完成不适用

The Application of Balanced Propofol Sedation in Fiberoptic Bronchoscopy

The Affiliated Hospital of Qingdao University1 个研究点 分布在 1 个国家目标入组 424 人开始时间: 2023年9月21日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
424
试验地点
1
主要终点
Patient satisfaction

研究概览

简要总结

The purpose of this study is to investigate the feasibility of using balanced propofol sedation for bronchoscopy. And screen out the optimal balanced propofol sedation compatibility plan.

详细描述

Balanced propofol sedation (BPS) is a technique proposed and developed by gastroenterologists. In recent years, multiple studies have confirmed that the use of BPS in gastrointestinal endoscopy can not only ensure patient comfort, but also reduce the incidence of respiratory and circulatory suppression. Moreover, the postoperative recovery time is short. Even for non-anesthesiologists applying BPS in gastrointestinal endoscopy , it has high safety.

Compared with gastrointestinal endoscopy, bronchoscopy occupies the respiratory tract and most patients have respiratory system diseases. Therefore, it is more necessary for strict respiratory management and control of patient sedation depth. Traditional midazolam combined with opioid drugs or propofol monosedation cannot effectively meet clinical needs. The excellent sedative and analgesic effects of BPS, as well as its maintenance of respiratory and circulatory functions, make it theoretically very suitable for application in bronchoscopy. However, there is currently a lack of evidence to support the application of BPS in bronchoscopy.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • American Society of Anesthesiologists classes I-IV ;
  • Patients undergo painless bronchoscopy, including bronchoscopic biopsy (bronchoscopic lesion biopsy, bronchial mucosal biopsy, bronchoscopic transmural lung biopsy, bronchoscopic needle aspiration biopsy) ,bronchoalveolar lavage and bronchoscopic treatment;
  • Normal communication skills and able to cooperate in completing this study;
  • Patients who voluntarily accept this experimental study and sign the "Trial Informed Consent Form".

排除标准

  • Patients with contraindications or allergies to anesthesia;
  • Individuals with a history of alcoholism or drug abuse;
  • Patients with contraindications for puncture of the cricoid membrane;
  • Patients with mental or neurological disorders, taking anti anxiety/depression drugs, or primary diseases with laboratory evidence indicating possible changes in hormone levels;
  • Patients with difficulty in language communication, poor understanding ability, and inability to cooperate in completing experimental studies;
  • Patients who require laryngeal mask or tracheal intubation for assisted ventilation during the examination process;
  • Patients undergoing rigid bronchoscopy treatment;
  • Patients who refuse to receive sedation or have not signed the "Trial Informed Consent Form".

研究组 & 干预措施

S-M group

Midazolam combines with sufentanil to titrate to moderate sedation for bronchoscopy.

干预措施: Midazolam and sufentanil (Drug)

S-M-P group

Midazolam and sufentanil combine with low-dose propofol to titrate to deep sedation for bronchoscopy.

干预措施: Midazolam, sufentanil and propofol (Drug)

S-R group

Remazolam combines with sufentanil to titrate to moderate sedation for bronchoscopy.

干预措施: Remazolam and sufentanil. (Drug)

S-R-P group

Remazolam and sufentanil combine with low-dose propofol to titrate to deep sedation for bronchoscopy.

干预措施: Remazolam, sufentanil and propofol (Drug)

结局指标

主要结局

Patient satisfaction

时间窗: During bronchoscopy.

The investigator needs to use VAS scores to evaluate satisfaction about sedation feeling when they accepted bronchoscopy. The score from 0 (extremely dissatisfied) to 10 (extremely satisfied).

Patient's recovery time

时间窗: The end of bronchoscopy (up to 2 hours).

The investigator needs to record the wake-up time of patients after the end of bronchoscopy.

Patient's departure time

时间窗: The end of bronchoscopy (up to 2 hours).

The investigator needs to record the patient's departure time after the end of bronchoscopy.

Clinical satisfaction

时间窗: During bronchoscopy.

The investigator needs to use VAS scores to evaluate satisfaction about doctors and nurses when they carry out the operation. The score from 0 (extremely dissatisfied) to 10 (extremely satisfied).

次要结局

  • Drug dosage(Before bronchoscopy and during bronchoscopy.)
  • Additional frequency of 2% lidocaine during bronchoscopy(During bronchoscopy.)
  • Additional dosage of 2% lidocaine during bronchoscopy(During bronchoscopy.)
  • Additional frequency of propofol during bronchoscopy(During bronchoscopy.)
  • Induction time(Before bronchoscopy.)
  • Additional dosage of propofol during bronchoscopy(During bronchoscopy.)
  • Patient response score during bronchoscopy(During bronchoscopy.)
  • Adverse reactions during bronchoscopy(During bronchoscopy)
  • Adverse reactions after fully awake(The end of bronchoscopy (up to 2 hours).)
  • Patient's anxiety/depression state(Day before bronchoscopy. 1, 3, 7, and 14 days after bronchoscopy.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

jixiangyu

Principal Investigator

The Affiliated Hospital of Qingdao University

研究点 (1)

Loading locations...

相似试验